| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 27-Jan-07 | | Total Revenue | 2,950,563 | 2,894,693 | 2,237,553 | | Cost of Revenue | 1,426,624 | 1,497,796 | 1,100,241 | | | Gross Profit | 1,523,939 | 1,396,897 | 1,137,312 | | | Operating Expenses | | Research Development | 929,990 | 988,996 | 658,211 | | Selling General and Administrative | 265,761 | 349,901 | 290,257 | | Non Recurring | 9,689 | 7,856 | 77,800 | | Others | 153,323 | 155,734 | 109,987 | | | | Total Operating Expenses | 1,358,763 | 1,502,487 | 1,136,255 | | | | Operating Income or Loss | 165,176 | (105,590) | 1,057 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23,651 | 37,844 | 23,756 | | Earnings Before Interest And Taxes | 188,827 | (67,746) | 24,813 | | Interest Expense | 17,994 | 40,498 | 10,207 | | Income Before Tax | 170,833 | (108,244) | 14,606 | | Income Tax Expense | 23,591 | 6,183 | 35,547 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 147,242 | (114,427) | (20,941) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 8,846 | | Other Items |
-
|
-
|
-
| | | | Net Income | 147,242 | (114,427) | (12,095) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $147,242 | ($114,427) | ($12,095) |
|
1.48% Nasdaq 
Income Statement
